
Candy giant Mars has partnered with biotech firm Pairwise to utilize CRISPR gene-editing technology for developing more resilient cocoa plants. This strategic collaboration aims to secure a stable and sustainable cocoa supply by creating cacao varieties more resistant to climate-related stresses like disease and heat, thereby mitigating significant supply chain risks for the global chocolate industry. The initiative underscores a growing trend among major food companies to invest in advanced biotechnologies to enhance agricultural resilience and ensure critical raw material availability.
Mars has initiated a strategic partnership with biotech firm Pairwise to employ CRISPR gene-editing technology, a proactive measure to secure its cocoa supply chain against climate-related threats. This collaboration provides Mars with access to Pairwise's Fulcrum platform, enabling the accelerated development of cacao plants with enhanced resistance to heat and disease, thereby mitigating long-term risks to a critical raw material. This move is indicative of a broader industry trend where major food and beverage corporations are leveraging advanced biotechnology to de-risk agricultural inputs, as evidenced by Starbucks' (SBUX) parallel investments in developing climate-resilient coffee. The application of a technology previously prominent in healthcare, such as the recently FDA-approved sickle cell treatment, to agriculture highlights the expanding commercialization of gene-editing and its increasing importance as a tool for ensuring supply chain stability and sustainability.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment